Developing cancer treatments directed at critical developmental pathway

Apr 10, 2008

Researchers from the University of Pennsylvania School of Medicine and colleagues discovered that the Notch signaling pathway, which determines the development of many cell types, and is also implicated in some cancers, is not universally essential for the maintenance of stem cells. The findings appear this week in Cell Stem Cell, and indicate that inhibitors of Notch may not affect bone marrow stem cells.

Notch is one of a select set of proteins that influence the development of a wide variety of types of cells. Prior work has shown that increases in signals generated by Notch are important in certain human tumors, particularly some kinds of childhood leukemia, making Notch an attractive target for new cancer therapies.

However, it has also been suggested that Notch is needed to maintain the stem cells in the bone marrow from which normal blood cells are formed, raising the concern that Notch inhibitors might destroy the normal bone marrow. “This potential risk raised important questions about treating leukemia patients with Notch inhibitors,” notes senior author Warren Pear, MD, PhD, Associate Professor of Pathology and Laboratory Medicine and the Abramson Family Cancer Research Institute.

Previous work from the Pear lab and others has shown that Notch signals are required for the proper development of lymphocytes. More importantly in terms of human disease, work done together with co-author Jon Aster’s lab at Harvard over the last decade has shown that abnormal increases in Notch signaling cause T-cell acute lymphoblastic leukemias, which make up about 15-20 percent of childhood leukemias. Growth of these leukemias can be stopped in the laboratory by new kinds of Notch pathway inhibitors.

“We have several projects focused on the development of new leukemia therapies that are designed to inhibit Notch,” notes Pear. “But it was important to know if this would have detrimental effects on bone marrow stem cells.”

This new work from the Pear group and colleagues showed definitively that adult bone marrow stem cells do not require Notch signals, indicating that it should be possible to give these inhibitors to patients without fear of causing bone marrow failure.

Source: University of Pennsylvania

Explore further: Scientist discovers populations of rare songbird in surprising new habitat

add to favorites email to friend print save as pdf

Related Stories

Promoting healing by keeping skeletal stem cells 'young'

Mar 30, 2010

Scientists seeking new ways to fight maladies ranging from arthritis and osteoporosis to broken bones that won't heal have cleared a formidable hurdle, pinpointing and controlling a key molecular player to keep stem cells ...

Recommended for you

Himalayan Viagra fuels caterpillar fungus gold rush

3 hours ago

Overwhelmed by speculators trying to cash-in on a prized medicinal fungus known as Himalayan Viagra, two isolated Tibetan communities have managed to do at the local level what world leaders often fail to ...

Science casts light on sex in the orchard

6 hours ago

Persimmons are among the small club of plants with separate sexes—individual trees are either male or female. Now scientists at the University of California, Davis, and Kyoto University in Japan have discovered ...

Researchers capture picture of microRNA in action

6 hours ago

Biologists at The Scripps Research Institute (TSRI) have described the atomic-level workings of "microRNA" molecules, which control the expression of genes in all animals and plants.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.